In vitro cytotoxicity experiments and intracellular fate study have been carried out by incubating the SN22 and SN46 samples before and after TSPO ligand conjugation with U87-MG human glioblastoma cancer cells, purposely chosen as in vitro cancer model since they overexpress the TSPO receptor [45,46]. The gene discussed is TSPO; the disease is cancer.